Direct Oral Anticoagulant Inhibitors: Mode of Action, Clinical Aspects
Handbook of Experimental Pharmacology · 2025
DOI: 10.1007/164_2025_786 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Handbook of Experimental Pharmacology, 2025. Verfasst von Eman Hassan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK. eman.hassan@uhb.nhs.uk. Hauptthemen laut MEDLINE: Anticoagulants, Factor Xa Inhibitors, Blood Coagulation. Die Arbeit nennt 81 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK. eman.hassan@uhb.nhs.uk.
- Department of Haematology, Queen Elizabeth Hospital, Birmingham, UK. eman.hassan@uhb.nhs.uk.
- Department of Cardiovascular Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.
- Department of Haematology, Queen Elizabeth Hospital, Birmingham, UK.
ORCID-Profile: Eman Hassan
Zitieren
APA
Hassan, E., & Lester, W. (2025). Direct Oral Anticoagulant Inhibitors: Mode of Action, Clinical Aspects. Handbook of Experimental Pharmacology. https://doi.org/10.1007/164_2025_786
Vancouver
Hassan E, Lester W. Direct Oral Anticoagulant Inhibitors: Mode of Action, Clinical Aspects. Handbook of Experimental Pharmacology. 2025. doi:10.1007/164_2025_786
BibTeX
@article{Hassan2025,
author = {Hassan, Eman and Lester, Will},
title = {Direct Oral Anticoagulant Inhibitors: Mode of Action, Clinical Aspects},
journal = {Handbook of Experimental Pharmacology},
year = {2025},
doi = {10.1007/164_2025_786}
}
EUVIMED